A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong

Launched by CHINESE UNIVERSITY OF HONG KONG · Aug 31, 2020

Keywords

ClinConnect Summary

This clinical trial is studying bronchiectasis, a lung condition that leads to frequent respiratory infections and can cause serious health issues. Researchers want to understand why some patients experience worsening symptoms, known as exacerbations, and to learn more about the outcomes for people living with this condition in Hong Kong. The goal is to gather updated information that can help doctors provide better care and management for patients with bronchiectasis.

To participate in this study, you need to be at least 18 years old and have been stable (not showing any worsening symptoms) for at least four weeks before joining. You will be required to have a specific type of imaging test, called a high-resolution CT scan, that confirms your diagnosis of bronchiectasis. During the trial, participants can expect to provide information about their health and experience with the condition. It’s important to note that people with certain other health issues or those who cannot give consent are not eligible to join. This research aims to improve understanding and treatment of bronchiectasis, benefiting patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients aged 18 years or older
• • 2. Clinically stable for at least 4 weeks prior to enrollment (defined as no symptoms of exacerbation, no requirement for supplemental antibiotic therapy)
• • 3. Diagnosis of bronchiectasis defined by high-resolution computed tomography scan
• Exclusion Criteria:
• • 1. History of cystic fibrosis; hypogammaglobulinemia; allergic bronchopulmonary aspergilosis
• • 2. Those who are unable to give consent